Community/Retail

Findings support the value of expanding this type of health care for patients with opioid use disorder.

The FDA initially approved baloxavir marboxil in October 2018 for the treatment of acute, uncomplicated influenza.

Researchers suggest that understanding the incubation period of COVID-19 and its individual strains could determine the isolation period.

Viloxazine ER treatment was associated with symptom, function, and clinical improvement in adults with attention-deficit hyperactivity disorder.

The mainstay of treatment for schizophrenia and schizoaffective disorder includes antipsychotics.

Doug Long and Scott Biggs of IQVIA discussed how data from Australia can help predict the strength of the upcoming flu season.

Patients with chronic migraines and higher frequencies of pain experienced the lowest vitamin B12 levels compared with patients with less frequent or no headache symptoms.

Flublok Quadrivalent and Fluzone High-Dose Quadrivalent are both proven to prevent more cases in older adults compared with a standard-dose vaccine in randomized controlled trials.

Pre-specified pooled analysis from phase 3 trials demonstrates 14% reduction in CV mortality and from any cause by 10% in individuals with HF, irrespective of ejection fraction.

A new statement from the American Heart Association stresses withdrawal medications and special care teams to prevent endocarditis in these individuals.

Cognitive harm appears reversible, results of analysis by Nemours Children’s Health Jacksonville and Stanford University shows.

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses why pharmacy technicians are leaving the profession and why they are staying.

Another market innovation continues the bifurcation of the profession's practice as community pharmacies become generics businesses.

Patients who had previously hit their out-of-pocket maximums could see a significant change.

AI-based technologies are increasingly being used for things such as virtual screening, physics-based biological activity assessment, and drug crystal-structure prediction.

Researchers suggest that more public health measures should be taken to address disparities among adults boosted for COVID-19.

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacists and pharmacy technicians can advocate for the certification of pharmacy technicians.

The COVID-19 pandemic impacted people experiencing homeless, though estimates remain unknown and highlights a need for more inclusive data.

Statins have been found to moderately benefit patients with cardiovascular disease risk factors, but researchers found socioeconomic disparities among those treated with statins.

Addiction to checking the news can worsen mental and physical illness, and in many cases may require individuals to reduce, or even stop, consuming any news.

Research indicates that there is a growing amount of unusual hepatitis cases in children throughout Europe.

Very short sleep among adolescents linked to a more than 70% increased risk of obesity/overweight in children, compared to those who get optimal 8 hours.

Memantine HCl (Namenda) is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.

Doan’s magnesium salicylate tetrahydrate formulation treats pain from backaches.

School-aged children that self-swabbed for COVID-19 did so with almost as much accuracy as a health care provider, which could ease strain on school health care systems.

Scott Biggs and Doug Long of IQVIA discussed where the pharmacy industry stands now and what they predict for the future.

An overview of the legal and business tools available to community, specialty, hospital, and health-system pharmacies in seeking to maintain payer network access and combat abusive practices.

It is not a leap to think that the 2022-2023 season could be worse than the past 2 seasons.

Although it may not have immediate significant impacts for many patients, the Inflation Reduction Act could open the door for future changes.

Rina Shah, PharmD, discussed the growing role for pharmacists in encouraging holistic health and wellness for patients.